Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rapid protocolized versus conventional atropine dosing in organophosphate poisoning
TCTR20261031015Phase 2Completed
- Start
- Jan 2026
- Modality
- Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of atropine in organophosphate poisoning (2 arms), sponsored by None. Primary endpoint: Total dose required for effect in 24 hours. Started Jan 2026; status: completed.
02
Drugs
atropine
03
Conditions
organophosphate poisoning
Beyond the preview
Go deeper on TCTR20261031015.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20261031015.